TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase II Study of Durvalumab for Bacillus Calmette-Guerin (BCG) Unresponsive Urothelial Carcinoma In Situ of the Bladder.

Roger Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.